Adjuvant Chemotherapy for Pseudomyxoma Peritonei from Appendiceal Adenocarcinoma
Author Information
Author(s): Chen Chin-Fan, Huang Che-Jen, Kang Wan-Yi, Hsieh Jan-Sing
Primary Institution: Kaohsiung Medical University Hospital
Hypothesis
Can systemic chemotherapy improve outcomes for patients with pseudomyxoma peritonei secondary to appendiceal mucinous adenocarcinoma?
Conclusion
Systemic chemotherapy may play a new role in treating pseudomyxoma peritonei, as demonstrated by the patient's excellent response after treatment.
Supporting Evidence
- The patient showed excellent response to chemotherapy after surgery.
- Follow-up imaging revealed no local recurrence or metastasis.
- The case highlights a potential new treatment approach for a rare condition.
Takeaway
A man with a rare belly condition got better after doctors used a special medicine to treat it, showing that this medicine might help others too.
Methodology
The patient underwent surgery to remove the tumor and received 10 cycles of systemic chemotherapy using the FOLFOX4 regimen.
Limitations
The study is based on a single case report, limiting the generalizability of the findings.
Participant Demographics
One 55-year-old male patient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website